⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

AN2 Therapeutics, Inc. Common Stock

$4.78
-0.19 (-3.73%)

Volume:

110.161K ($526.06K)

Market Capitalization:

$180.19M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

AN2 Therapeutics Market Segments

Regular Trading Hours

-0.23(-4.50%)
Open$5.00
Close$4.78
Low$4.70
Low Change-0.30 (-6.00%)
High$5.05
High Change+0.05 (+1.00%)
Range$0.35
Volume109.961K
Dollar Volume$525.06K

Premarket

+0.00(+0.00%)
Open$4.96
Close$4.96
Low$4.96
Low Change0.00 (0.00%)
High$4.96
High Change+0.00 (+0.00%)
Range$0.00
Volume200
Dollar Volume$992.00

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$4.96
Close$4.96
Low$4.96
Low Change0.00 (0.00%)
High$4.96
High Change+0.00 (+0.00%)
Range$0.00
Volume32.073K
Dollar Volume$159.08K

Regular Trading Hours Yesterday

-0.10(-1.98%)
Open$5.06
Close$4.96
Low$4.92
Low Change-0.14 (-2.77%)
High$5.25
High Change+0.19 (+3.75%)
Range$0.33
Volume263.331K
Dollar Volume$1.31M

Premarket Yesterday

*No Trades in Segment

AN2 Therapeutics News

There is no current news for this stock at the moment.

AN2 Therapeutics Top Trades

AN2 Therapeutics's top trade so far today returned +1.81%, while the top short trade returned -6.00%.

AN2 Therapeutics Moving Averages

5 Day Moving Average (SMA5)$5.12
10 Day Moving Average (SMA10)$5.39
20 Day Moving Average (SMA20)$5.54
50 Day Moving Average (SMA50)$5.45
100 Day Moving Average (SMA100)$5.02
200 Day Moving Average (SMA200)$3.60

AN2 Therapeutics Statistics

Average Volume (30 Days)223.85K
P/E Ratio (Current)-5.26
EPS (Current)-$0.96
Dividend Yield0.00%
Free Cash Flow-$30.68M
Cash Ratio7.94
Current Ratio14.32
Quick Ratio14.32
Debt to Equity0.00
Enterprise Value$146.25M
EV to EBITDA-3.77
EV to Sales
Price to Book2.51
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.44%
Return on Equity-0.48%

AN2 Therapeutics Stock Splits

There have been no stock splits for AN2 Therapeutics (ANTX).

AN2 Therapeutics Dividends

There have been no dividends for AN2 Therapeutics (ANTX).